Diabetic neuropathy will be the focus of August 6 Visiting Professor Lecture

Two eminent neurologists will visit Ann Arbor on August 6 to present their latest research findings at a Visiting Professor Lecture hosted by the A. Alfred Taubman Medical Research Institute at the University of Michigan.

Amanda Peltier, M.D., a clinician-scientists and assistant professor of neurology at Vanderbilt University in Nashville, is an authority in the field of diabetic neuropathy.  Her research focuses on developing means to diagnose neuropathy at earlier stages where it may be treatable. 

Dr. Peltier completed her residency in neurology in 2002, and her M.S. in clinical research design in 2005.She has been awarded the Samuel J. Roessler Memorial Medical Scholarship, and has been recognized by the Landacre Society, College of Medicine Research Honorary Society. She has also received the IFCN Young Investigator Fellowship Award.

Dr. Peltier has been awarded the Samuel J. Roessler Memorial Medical Scholarship, and has been recognized by the Landacre Society, College of Medicine Research Honorary Society. She has also received the IFCN Young Investigator Fellowship Award.

Troels Staehelin Jensen, M.D., DMSc, of the Aarhus University in Denmark, is a renowned expert in the neurophysiology of pain.  As a clinician-scientist, he has extensively studied the neuropathology of pain and is the author of more than 300 scientific papers.  He is chair of the Aarhus University Hospital Department of Neurology, a founder of the Danish Pain Research Center, has held numerous academic posts and is a past president of the International Association for the Study of Pain.

Dr. Peltier will speak about "Diabetic neuropathy: A tale of two diseases" at 9:30 a.m. on August 6.  Dr. Jensen will present his lecture, "Mechanisms and evidence based treatment of neuropathic pain" at 10:30 a.m.

Both talks will take place in the Danto Auditorium of the U-M Cardiovascular Center.  No registration is required; all are welcome to attend.

Click here for directions and parking information for the Danto Auditorium.

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

 

Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster

 

video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists